Advertisement
Screener

Valion Bio, Inc. (VBIO) Material Contracts

Valion Bio, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-09-23: Form 8-K; Exhibit 10.1; Description CONSULTING AGREEMENT.
  • 2026-09-01: Form 8-K; Exhibit 10.1; Description LETTER AGREEMENT WITH 3I, LP DATED 8-27-26.
  • 2026-08-17: Form 8-K; Exhibit 10.2; Description FORM OF ROYALTY AGREEMENT.
  • 2026-08-17: Form 8-K; Exhibit 10.1; Description LETTER AGREEMENT BETWEEN THE COMPANY AND 3I, LP.
FiledFormExhibitDescription
2026-09-238-K10.1CONSULTING AGREEMENT
2026-09-018-K10.1LETTER AGREEMENT WITH 3I, LP DATED 8-27-26
2026-08-178-K10.2FORM OF ROYALTY AGREEMENT
2026-08-178-K10.1LETTER AGREEMENT BETWEEN THE COMPANY AND 3I, LP
2026-06-038-K10.1SECOND AMENDMENT 2021 EQUITY INCENTIVE PLAN
2026-05-048-K10.1TIVIC HEALTH EXECUTIVE EMPLOYMENT AGREEMENT
2026-03-138-K10.3SUBLEASE
2026-03-138-K10.2LEASE
2026-03-138-K10.1BUILDING LEASE AGREEMENT
2026-03-048-K10.1SEPARATION AGREEMENT
2026-02-098-K10.2REGISTRATION RIGHTS AGREEMENT
2026-02-098-K10.1COMMON STOCK PURCHASE AGREEMENT
2025-12-118-K10.7AMENDMENT TO SERIES B PREFERRED SPA
2025-12-118-K10.6SERIES C PREFERRED RRA
2025-12-118-K10.5SECURITIES PURCHASE AGREEMENT (PREFERRED OFFERING)
2025-12-118-K10.4REGISTRATION RIGHTS AGREEMENT
2025-12-118-K10.3SECURITY AGREEMENT
2025-12-118-K10.2NOTE
2025-12-118-K10.1SECURITIES PURCHASE AGREEMENT
2025-10-158-K10.1Executive Employment Agreement, by and between Tivic Health Systems, Inc. and Jennifer Ernst, dated October 8, 2025.
2025-07-258-K/A10.1Amended and Restated Exclusive License Agreement, dated June 18, 2025, by and between Tivic Health Systems, Inc. and Statera Biopharma, Inc.
2025-07-078-K10.2First Amendment to Tivic Health Systems, Inc. Amended and Restated 2021 Equity Incentive Plan, dated June 30, 2025.
2025-07-078-K10.1Executive Employment Agreement, by and between Tivic Health Systems, Inc. and Lisa Wolf, effective July 7, 2025.
2025-06-258-K10.1Amended and Restated Exclusive License Agreement, dated June 18, 2025, by and between Tivic Health Systems, Inc. and Statera Biopharma, Inc.
2025-05-1510-Q10.8Statement of Work, by and between Tivic Health Systems, Inc. and Scorpius BioManufacturing, Inc., dated May 9, 2025.
2025-05-028-K10.2Registration Rights Agreement, by and between Tivic Health Systems, Inc. and Helena Global Investment Opportunities 1 Ltd., dated April 29, 2025.
2025-05-028-K10.1Securities Purchase Agreement, by and between Tivic Health Systems, Inc. and Helena Global Investment Opportunities 1 Ltd., dated April 29, 2025.
2025-03-218-K10.2Registration Rights Agreement, by and between Tivic Health Systems, Inc. and Mast Hill, L.P., dated March 18, 2025.
2025-03-218-K10.1Equity Purchase Agreement, by and between Tivic Health Systems, Inc. and Mast Hill, L.P., dated March 18, 2025.
2025-02-248-K10.1Executive Employment Agreement, by and between Tivic Health Systems, Inc. and Michael Handley, dated February 18, 2025.
2025-02-128-K10.2Securities Purchase Agreement, dated February 11, 2025, by and between the Tivic Health Systems, Inc. and Statera Biopharma, Inc.
2025-02-128-K10.1Exclusive License Agreement, dated February 11, 2025, by and between the Tivic Health Systems, Inc. and Statera Biopharma, Inc.
2024-08-138-K10.1Tivic Health System, Inc. Amended and Restated 2021 Equity Incentive Plan, dated August 9, 2024.
2024-05-308-K10.1Sublease Termination Agreement, dated May 21, 2024, by and between Tivic Health Systems, Inc. and Czarnowski Display Service, Inc.
2024-05-228-K10.1Collaboration and Research Support Agreement, dated May 17, 2024, by and between Tivic Health Systems, Inc. and The Feinstein Institutes for Medical Research.
2024-05-138-K10.2Placement Agency Agreement, dated May 9, 2024 by and between Tivic Health Systems, Inc. and Maxim Group, LLC.
2024-05-138-K10.1Form of Securities Purchase Agreement, dated May 9, 2024, by and between Tivic Health Systems, Inc. and the investors party thereto.
2024-03-2510-K10.16Amendment #1 to Fulfillment Services Agreement, between Tivic Health Systems, Inc. and ALOM Technologies Corporation, dated March 5, 2024.
2023-08-098-K10.2Placement Agency Agreement, dated August 6, 2023, by and between Tivic Health Systems, Inc. and Maxim Group LLC.
2023-08-098-K10.1Form of Securities Purchase Agreement, dated August 6, 2023, by and between Tivic Health Systems, Inc. and the investors party thereto.
2023-07-198-K10.2Placement Agency Agreement, dated July 14, 2023, by and between Tivic Health Systems, Inc. and Maxim Group LLC.
2023-07-198-K10.1Form of Securities Purchase Agreement, dated July 14, 2023, by and between Tivic Health Systems, Inc. and the investors party thereto.
2023-07-118-K10.2Placement Agency Agreement, dated July 10, 2023, by and between Tivic Health Systems, Inc. and Maxim Group LLC.
2023-07-118-K10.1Form of Securities Purchase Agreement, dated July 10, 2023, by and between Tivic Health Systems, Inc. and the investors party thereto.
2022-12-018-K10.1Fulfillment Services Agreement, dated November 25, 2022, by and between Tivic Health Systems, Inc. and ALOM Technologies Corporation.
2022-10-258-K10.1Manufacturing Agreement, dated October 21, 2022, by and between Tivic Health Systems, Inc. and Microart Services Inc.
2022-04-058-K10.2Executive Offer Letter, between Tivic Health Systems, Inc. and Ryan Sabia, dated April 1, 2022.
2022-04-058-K10.1Executive Offer Letter, between Tivic Health Systems, Inc. and Veronica Cai, dated April 1, 2022.
2022-03-3110-K10.21Sublease Agreement, between the Company and Czarnowski Display Services, Inc., dated November 17, 2021.

Similar stocks

Stock NameCountryMarket CapPE Ratio
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
iBio, Inc. (IBIO)United States$0.077B-2.94
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Lifevantage Corp (LFVN)United States$0.078B15.40
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
OS Therapies Inc (OSTX)United States$0.076B-2.17
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Cingulate Inc. (CING)United States$0.073B-2.64
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41